262 related articles for article (PubMed ID: 10806995)
1. Molecular mechanisms of action of antisense drugs.
Crooke ST
Biochim Biophys Acta; 1999 Dec; 1489(1):31-44. PubMed ID: 10806995
[TBL] [Abstract][Full Text] [Related]
2. Morpholino antisense oligomers: the case for an RNase H-independent structural type.
Summerton J
Biochim Biophys Acta; 1999 Dec; 1489(1):141-58. PubMed ID: 10807004
[TBL] [Abstract][Full Text] [Related]
3. Binding affinity and specificity of Escherichia coli RNase H1: impact on the kinetics of catalysis of antisense oligonucleotide-RNA hybrids.
Lima WF; Crooke ST
Biochemistry; 1997 Jan; 36(2):390-8. PubMed ID: 9003192
[TBL] [Abstract][Full Text] [Related]
4. Novel mechanisms for antisense-mediated regulation of gene expression.
Baker BF; Monia BP
Biochim Biophys Acta; 1999 Dec; 1489(1):3-18. PubMed ID: 10806993
[No Abstract] [Full Text] [Related]
5. The influence of antisense oligonucleotide-induced RNA structure on Escherichia coli RNase H1 activity.
Lima WF; Mohan V; Crooke ST
J Biol Chem; 1997 Jul; 272(29):18191-9. PubMed ID: 9218455
[TBL] [Abstract][Full Text] [Related]
6. Carba-LNA-5MeC/A/G/T modified oligos show nucleobase-specific modulation of 3'-exonuclease activity, thermodynamic stability, RNA selectivity, and RNase H elicitation: synthesis and biochemistry.
Upadhayaya R; Deshpande SG; Li Q; Kardile RA; Sayyed AY; Kshirsagar EK; Salunke RV; Dixit SS; Zhou C; Földesi A; Chattopadhyaya J
J Org Chem; 2011 Jun; 76(11):4408-31. PubMed ID: 21500818
[TBL] [Abstract][Full Text] [Related]
7. Molecular mechanisms of antisense drugs: RNase H.
Crooke ST
Antisense Nucleic Acid Drug Dev; 1998 Apr; 8(2):133-4. PubMed ID: 9593052
[No Abstract] [Full Text] [Related]
8. RNase H sequence preferences influence antisense oligonucleotide efficiency.
Kielpinski LJ; Hagedorn PH; Lindow M; Vinther J
Nucleic Acids Res; 2017 Dec; 45(22):12932-12944. PubMed ID: 29126318
[TBL] [Abstract][Full Text] [Related]
9. Antisense oligonucleotides: the state of the art.
Aboul-Fadl T
Curr Med Chem; 2005; 12(19):2193-214. PubMed ID: 16178780
[TBL] [Abstract][Full Text] [Related]
10. Is irrelevant cleavage the price of antisense efficacy?
Stein CA
Pharmacol Ther; 2000 Mar; 85(3):231-6. PubMed ID: 10739877
[TBL] [Abstract][Full Text] [Related]
11. Short-term and long-term modulation of gene expression by antisense therapeutics.
Sazani P; Vacek MM; Kole R
Curr Opin Biotechnol; 2002 Oct; 13(5):468-72. PubMed ID: 12459339
[TBL] [Abstract][Full Text] [Related]
12. Artificial cationic oligosaccharides for heteroduplex oligonucleotide-type drugs.
Hara RI; Hisada Y; Maeda Y; Yokota T; Wada T
Sci Rep; 2018 Mar; 8(1):4323. PubMed ID: 29531343
[TBL] [Abstract][Full Text] [Related]
13. 2'-carbohydrate modifications in antisense oligonucleotide therapy: importance of conformation, configuration and conjugation.
Manoharan M
Biochim Biophys Acta; 1999 Dec; 1489(1):117-30. PubMed ID: 10807002
[TBL] [Abstract][Full Text] [Related]
14. Site and mechanism of antisense inhibition by C-5 propyne oligonucleotides.
Moulds C; Lewis JG; Froehler BC; Grant D; Huang T; Milligan JF; Matteucci MD; Wagner RW
Biochemistry; 1995 Apr; 34(15):5044-53. PubMed ID: 7536034
[TBL] [Abstract][Full Text] [Related]
15. Determination of the role of the human RNase H1 in the pharmacology of DNA-like antisense drugs.
Wu H; Lima WF; Zhang H; Fan A; Sun H; Crooke ST
J Biol Chem; 2004 Apr; 279(17):17181-9. PubMed ID: 14960586
[TBL] [Abstract][Full Text] [Related]
16. Locked nucleic acids: a promising molecular family for gene-function analysis and antisense drug development.
Orum H; Wengel J
Curr Opin Mol Ther; 2001 Jun; 3(3):239-43. PubMed ID: 11497347
[TBL] [Abstract][Full Text] [Related]
17. An assessment of the antisense properties of RNase H-competent and steric-blocking oligomers.
Bonham MA; Brown S; Boyd AL; Brown PH; Bruckenstein DA; Hanvey JC; Thomson SA; Pipe A; Hassman F; Bisi JE
Nucleic Acids Res; 1995 Apr; 23(7):1197-203. PubMed ID: 7537874
[TBL] [Abstract][Full Text] [Related]
18. A critical survey of the structure-function of the antisense oligo/RNA heteroduplex as substrate for RNase H.
Zamaratski E; Pradeepkumar PI; Chattopadhyaya J
J Biochem Biophys Methods; 2001 May; 48(3):189-208. PubMed ID: 11384757
[TBL] [Abstract][Full Text] [Related]
19. Kinetic selectivity of complementary nucleic acids: bcr-abl-directed antisense RNA and ribozymes.
Kronenwett R; Haas R; Sczakiel G
J Mol Biol; 1996 Jun; 259(4):632-44. PubMed ID: 8683570
[TBL] [Abstract][Full Text] [Related]
20. RNase H-mediated inhibition of translation by antisense oligodeoxyribonucleotides: use of backbone modification to improve specificity.
Larrouy B; Blonski C; Boiziau C; Stuer M; Moreau S; Shire D; Toulmé JJ
Gene; 1992 Nov; 121(2):189-94. PubMed ID: 1332911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
